Find a Study

STUDY SEARCH RESULTS
  Notify Me When Search is Updated

7 studies found for your search request:  molnupiravir

A Study to Evaluate Molnupiravir (MK-4482) in Participants with Moderate Hepatic Impairment (MK-4482...
Condition: Hepatic Impairment
Minimum Age: 18 years, Maximum Age: 75 years
Gender: All
Study ID: NCT05386589
Status: Completed
Has Results

A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants with Severe Renal Impairment (MK-448...
Condition: Renal Impairment
Minimum Age: 18 years, Maximum Age: 75 years
Gender: All
Study ID: NCT05386758
Status: Completed
Has Results

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants with COVID-19 (MK-4...
Condition: Coronavirus Disease (COVID-19)
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04575584
Status: Terminated (Halted Prematurely)

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants with COVID-19 (...
Condition: Coronavirus Disease (COVID-19)
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04575597
Status: Completed
Has Results

Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza V...
Condition: influenza infection
Minimum Age: 18 years, Maximum Age: 55 years
Gender: All
Study ID: NCT05818124
Status: Not yet recruiting



Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site